Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Raine

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Journal of Crohn'S & Colitis|August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD DiagnosticsAart Mookhoek, Pieter Sinonque, Mariangela Allocca, et al.
The Journal of Experimental Medicine|September 18, 2013
ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cellsLukas Niederreiter, Teresa M J Fritz, Timon E Adolph, et al.
Journal of Crohn'S & Colitis|April 28, 2025
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trialsBryan Linggi, Salas Azucena, Boyd Steere, et al.
Inflammatory Bowel Diseases|August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United KingdomSamuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Nature Immunology|August 2, 2016
C13orf31 (FAMIN) is a central regulator of immunometabolic functionM Zaeem Cader, Katharina Boroviak, Qifeng Zhang, et al.
The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2019
Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysisShaji Sebastian, Sally Myers, Konstantinos Argyriou, et al.
Frontline Gastroenterology|September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemicNicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
Gut|April 27, 2021
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBDNicholas A Kennedy, Simeng Lin, James R Goodhand, et al.
BMJ Open Gastroenterology|November 30, 2024
Update from 2010 (standard operating procedure): protocol for the 2024 British Society of Gastroenterology Guidelines on colorectal surveillance in inflammatory bowel diseaseMorris Gordon, Gaurav Bhaskar Nigam, Vassiliki Sinopoulou, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Journal of Crohn'S & Colitis|August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD DiagnosticsAart Mookhoek, Pieter Sinonque, Mariangela Allocca, et al.
The Journal of Experimental Medicine|September 18, 2013
ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cellsLukas Niederreiter, Teresa M J Fritz, Timon E Adolph, et al.
Journal of Crohn'S & Colitis|April 28, 2025
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trialsBryan Linggi, Salas Azucena, Boyd Steere, et al.
Inflammatory Bowel Diseases|August 21, 2023
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United KingdomSamuel Hsiang Lim, Beatriz Gros, Esha Sharma, et al.
Nature Immunology|August 2, 2016
C13orf31 (FAMIN) is a central regulator of immunometabolic functionM Zaeem Cader, Katharina Boroviak, Qifeng Zhang, et al.
The Lancet. Gastroenterology & Hepatology|January 28, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementJames L Alexander, Gordon W Moran, Daniel R Gaya, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2019
Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysisShaji Sebastian, Sally Myers, Konstantinos Argyriou, et al.
Frontline Gastroenterology|September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemicNicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
Gut|April 27, 2021
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBDNicholas A Kennedy, Simeng Lin, James R Goodhand, et al.
BMJ Open Gastroenterology|November 30, 2024
Update from 2010 (standard operating procedure): protocol for the 2024 British Society of Gastroenterology Guidelines on colorectal surveillance in inflammatory bowel diseaseMorris Gordon, Gaurav Bhaskar Nigam, Vassiliki Sinopoulou, et al.
Pageof 11